A1RG34:BVMF
Argenx Se Bdr
187,38 BRL
0,00%
(0,00) 1D
6-окт., 14:05:54 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
58,69 млд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 BRL
52-wk low
143,22 BRL
Shares outstanding
62,89 млн
No. of employees
2 миң
Mkt. cap
58,69 млд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 BRL
52-wk low
143,22 BRL
Shares outstanding
62,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
AD HOC NEWS
·
2 саат мурун
Argenx stock gained 1.93 percent as pipeline access expands
AD HOC NEWS
·
7 саат мурун
Goldman Sachs raises target for Argenx stock to EUR 982.00
Investing.com UK
·
18 саат мурун
Halozyme expands argenx collaboration with two new targets By Investing.com
Stock Titan
·
18 саат мурун
A drug-delivery partnership expands from six exclusive targets to eight.
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr